Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Carlina Technologies

Carlina Technologies
2010 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$10.1M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of nanomedicines designed to relieve patients suffering from many diseases. The company's biopharmaceutical process utilizes innovative non-denaturing drug delivery technologies for therapeutic proteins, peptides and other types of drugs, enabling patients to improve compliance and quality of life.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • 22, rue Roger Amsler
  • 49100 Angers
  • France

+33 02 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Carlina Technologies’s full profile, request a free trial.

Carlina Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 03-Nov-2014 $10.1M 000.00 Completed Startup
2. Early Stage VC 06-Mar-2013 00000 Completed Startup
1. Early Stage VC 10-Dec-2012 $432K $432K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Carlina Technologies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Siparex Group PE/Buyout Minority 000 0000 000000 0
GO Capital (France) Venture Capital Minority 000 0000 000000 0
WBC Accelerator/Incubator 000 0000 000000 0

Carlina Technologies Executive Team (2)

Name Title Board
Seat
Contact
Info
Olivier Meyer Ph.D Co-Founder, President & Chief Executive Officer
Jean-Pierre Benoît Ph.D Co-Founder & Chairman of the Scientific Advisory Board

Carlina Technologies Board Members (3)

Name Representing Role Since Contact
Info
Bertrand Distinguin GO Capital (France) Board Member 000 0000
Jean-Pierre Benoît Ph.D Carlina Technologies Co-Founder & Chairman of the Scientific Advisory Board 000 0000
Leila Guerlain Nicolas GO Capital (France) Board Member 000 0000